The basal ganglia of patients in the early stages of PD have decreased levels of the PPP rate-limiting enzyme glucose-6-phosphate dehydrogenase (G6PD), which is responsible for regenerating NADPH from NADP to sustain cellular antioxidant defences [85]. The gene discussed is G6PD; the disease is Parkinson disease.